Insider Transactions in Q2 2024 at Select Medical Holdings Corp (SEM)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 09
2024
|
Rocco A Ortenzio CHAIRMAN EMERITUS & CO-FOUNDER |
BUY
Bona fide gift
|
Indirect |
200,000
+5.32%
|
-
|
|
May 09
2024
|
Rocco A Ortenzio CHAIRMAN EMERITUS & CO-FOUNDER |
SELL
Bona fide gift
|
Direct |
200,000
-29.85%
|
-
|
|
Apr 30
2024
|
Christopher Weigl CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+27.27%
|
-
|
|
Apr 30
2024
|
Brian R. Rusignuolo Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+17.29%
|
-
|
|
Apr 30
2024
|
Thomas P Mullin CO-PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+20.23%
|
-
|
|
Apr 30
2024
|
Martin F Jackson EXECUTIVE VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
138,000
+9.11%
|
-
|
|
Apr 30
2024
|
Michael F Malatesta CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+27.14%
|
-
|
|
Apr 30
2024
|
Michael E Tarvin EXECUTIVE VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
92,000
+14.81%
|
-
|
|
Apr 30
2024
|
John A. Saich EXECUTIVE VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+12.19%
|
-
|
|
Apr 30
2024
|
Parvinderjit S. Khanuja |
BUY
Grant, award, or other acquisition
|
Direct |
10,634
+10.36%
|
$148,876
$14.19 P/Share
|
|
Apr 30
2024
|
Daniel Thomas |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+13.16%
|
-
|
|
Apr 30
2024
|
Robert A Ortenzio EXECUTIVE CHAIRMAN |
BUY
Grant, award, or other acquisition
|
Direct |
230,000
+3.22%
|
-
|
|
Apr 30
2024
|
David S Chernow PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
230,000
+16.4%
|
-
|
|
Apr 30
2024
|
Rocco A Ortenzio CHAIRMAN EMERITUS & CO-FOUNDER |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+12.99%
|
-
|
|
Apr 30
2024
|
William H. Frist |
BUY
Grant, award, or other acquisition
|
Direct |
10,634
+1.81%
|
$148,876
$14.19 P/Share
|
|
Apr 30
2024
|
James S. Ely Iii |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+6.34%
|
-
|
|
Apr 30
2024
|
Marilyn B Tavenner |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+15.63%
|
-
|
|
Apr 30
2024
|
Katherine R Davisson |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+17.86%
|
-
|
|
Apr 30
2024
|
Robert G. Breighner Jr VICE PRESIDENT, COMPLIANCE |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+15.55%
|
-
|
|
Apr 30
2024
|
Thomas Scully Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+10.06%
|
-
|
|
Apr 30
2024
|
Russell L Carson Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+0.9%
|
-
|
|
Apr 28
2024
|
Robert G. Breighner Jr VICE PRESIDENT, COMPLIANCE |
SELL
Payment of exercise price or tax liability
|
Direct |
1,985
-6.02%
|
$53,595
$27.41 P/Share
|
|
Apr 08
2024
|
Robert A Ortenzio EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct |
50,000
-0.74%
|
$1,450,000
$29.9 P/Share
|